| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0091-6749(81)90196-2 |
| P698 | PubMed publication ID | 7031111 |
| P2093 | author name string | M M Weinberger | |
| R A Prince | |||
| S Riegelman | |||
| D S Wing | |||
| L S Hendeles | |||
| P433 | issue | 6 | |
| P921 | main subject | erythromycin | Q213511 |
| P304 | page(s) | 427-431 | |
| P577 | publication date | 1981-12-01 | |
| P1433 | published in | The Journal of Allergy and Clinical Immunology | Q7743550 |
| P1476 | title | Effect of erythromycin on theophylline kinetics | |
| P478 | volume | 68 |
| Q40174727 | A Clinical and Pharmacokinetic Basis for the Selection and Use of Slow Release Theophylline Products |
| Q43240373 | Arbaprostil (15(R)-15-methyl PGE2): lack of effect on theophylline metabolism |
| Q38657865 | Clinical pharmacokinetic properties of the macrolide antibiotics. Effects of age and various pathophysiological states (Part II). |
| Q39554942 | Drug interactions that matter. A critical reappraisal |
| Q68816886 | Effect of miocamycin on theophylline kinetics in children |
| Q34447082 | Enoxacin decreases the clearance of theophylline in man. |
| Q41763930 | Enprofylline disposition in the presence and absence of amoxycillin or erythromycin |
| Q69573068 | Evaluation of a scheme for establishing and maintaining dosage of theophylline in ambulatory patients with chronic asthma |
| Q27009128 | Importance of multi-p450 inhibition in drug-drug interactions: evaluation of incidence, inhibition magnitude, and prediction from in vitro data |
| Q92283346 | Improving antibacterial prescribing safety in the management of COPD exacerbations: systematic review of observational and clinical studies on potential drug interactions associated with frequently prescribed antibacterials among COPD patients |
| Q40467542 | Influence of endogenous and exogenous effectors on the pharmacokinetics of theophylline. Focus on biotransformation. |
| Q34049823 | Macrolide - induced clinically relevant drug interactions with cytochrome P-450A (CYP) 3A4: an update focused on clarithromycin, azithromycin and dirithromycin |
| Q40423079 | Macrolide antibacterials. Drug interactions of clinical significance |
| Q69021394 | Non-interaction of ketotifen and theophylline in children with asthma--an acute study |
| Q36869460 | Pharmacokinetic Drug Interactions in Anaesthetic Practice |
| Q40094923 | Pharmacokinetic Drug Interactions with Theophylline |
| Q36648776 | Pharmacokinetic Interactions Between Theophylline and Other Medication (Part II) |
| Q24631021 | Pharmacokinetic drug interactions of antimicrobial drugs: a systematic review on oxazolidinones, rifamycines, macrolides, fluoroquinolones, and Beta-lactams |
| Q35759081 | Pharmacokinetic drug interactions of macrolides |
| Q40720380 | Pharmacokinetic drug interactions with antimicrobial agents |
| Q39814639 | Pharmacokinetic interactions of the macrolide antibiotics |
| Q71049790 | Practical considerations in the safe and effective use of theophylline |
| Q42047580 | Seizures from theophylline use |
| Q39525952 | Sustained release theophylline preparations. Practical recommendations for prescribing and therapeutic drug monitoring |
| Q44747787 | The effect of the 4-quinolone enoxacin on plasma theophylline concentrations |
| Q70331073 | Theophylline |
| Q40150067 | Theophylline A “State of the Art” Review |
| Q39749509 | Theophylline poisoning. Pharmacological considerations and clinical management |
| Q98160357 | Volume of Distribution is Unaffected by Metabolic Drug-Drug Interactions |
| Q69501354 | [Pharmacokinetic interactions of macrolides and theophylline] |
Search more.